The high-profile case of Luigi Mangione, who shot and killed “United Health Care” CEO Brian Thompson, has been over a year since the incident took place, but it has recently gained renewed attention. The reason being several key court hearings that have taken place since January 9th. The latest development is that Luigi’s state-level case will go to trial in June, while the federal case is scheduled for October.
On the day of the January 9th court appearance, silence fell over the courtroom as the defendant, Luigi, dressed in a yellow-green prison uniform, entered. Standing at 1.8 meters tall with a handsome face, the alleged assailant had become a well-known figure in the United States since December 4, 2024.
Fourteen months ago on a clear morning, Luigi, a Ivy League graduate from a wealthy family in Maryland, laid in wait outside the Hilton Hotel on West 54th Street in Midtown Manhattan. As CEO Thompson of United Health Care appeared on the sidewalk, Luigi pulled the trigger, callously shooting the father of two in an execution-style manner. Thompson staggered and fell to the ground, succumbing to the fatal gunshot wounds.
After the incident, the police found words like “delay,” “deny,” and “depose” inscribed on the bullets. This reminded Americans of a book by Jay Feinman, a professor of insurance law at Rutgers University, titled “Delayed, Denied, Dismissed — Why Insurance Companies Don’t Pay and What You Can Do About It.”
The case has ignited nationwide resentment towards health insurance companies, and each time Luigi’s court hearing takes place, a large crowd of his supporters gathers outside.
“I work in the healthcare industry, and I have seen many people suffer,” said Breigh Marquisette, a 44-year-old legal assistant from Philadelphia who attends every one of Luigi’s court sessions. She emphasized, “But that cannot justify murder,” before adding, “However, this has become a platform. He (Luigi) has become a symbol of the flaws in the system. Unfortunately, it took such an incident for people to pay attention to the healthcare system.”
Marquisette and her companions held signs saying “Against the Death Penalty” and “Free Luigi,” hoping that this case would bring change to the health insurance system. “So, in my opinion, the significance of this case has transcended Luigi himself,” she said.
According to a Manhattan Supreme Court indictment, a New Jersey woman named Nancy, who had been insured by United Health Care and another related insurance company for several decades, relied on the insurance companies to reimburse her for her prescription for Lexapro to treat her chronic anxiety disorder.
In 2011, Nancy’s anxiety symptoms worsened, but she discovered that the insurance company had switched her medication without her knowledge from Lexapro to a generic drug and another generic medication. The insurance company only allowed reimbursement for these two drugs, refusing to cover Lexapro. Despite her numerous protests, as her condition could only be managed with Lexapro, Nancy had to pay $473 out of pocket every month for her medication.
This practice in the American health insurance industry, known as “Prior Authorization” (PA), requires insurance companies to review and approve certain medical services, treatments, or medications before they can be used. In other words, you can only use a specific treatment or medication if the insurance company agrees to cover it; otherwise, you either follow the insurance company’s recommended reimbursable drugs or pay for the medication yourself.
The Affordable Care Act of 2010, commonly known as Obamacare, set new standards for which individuals and which items insurance plans must cover. With rising healthcare costs, insurance companies increasingly use prior authorization procedures to review medical service applications before agreeing to pay.
Shirley Huang, the Executive Director of the CAIPA Foundation, expressed that PA has been a common practice in the medical field for decades, especially in the use of medications and surgeries. Huang stated, “This poses a significant challenge for many patients and for our doctors in the healthcare industry.”
Dr. Liu Jigao, President and CEO of the CAIPA, mentioned that the complexities within the US healthcare system, such as exorbitant drug prices and the substantial medical expenses incurred by illegal immigrants, contribute to the challenges faced. He highlighted the constraints imposed by limited government funding and the abuse of the Medicaid system.
Since the Luigi case, over 38,000 people have donated more than $1.4 million for his legal defense fund on the donation website GiveSendGo. Luigi’s legal team confirmed that they have accepted these donations to fund his legal battles.
Luigi is currently facing three lawsuits – one federal and two state-level cases in New York and Pennsylvania. A key ruling on February 6 by New York State Judge Gregory Carro scheduled the state trial to commence on June 8, enraging Luigi’s defense team who argued that handling two prosecution teams in such a short timeframe is too rushed.
Despite the protection of the Fifth Amendment preventing double jeopardy for the same crime, the legal basis for the Luigi case lies in the “dual sovereignty principle,” which allows both federal and state governments to prosecute individuals for violations of two separate sets of laws.
As the legal proceedings continue, the complex issues surrounding the healthcare system and insurance practices in the United States remain a topic of heated debate and scrutiny among the public.